World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
65
Citations
15895
World Ranking
2837
National Ranking
1343

Igal Gery publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Igal Gery sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 342 publications — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Igal Gery D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Igal Gery sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 65 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Igal Gery is a researcher affiliated with the National Institutes of Health in the United States. Their work lies primarily within the fields of Immunology and Microbiology, as well as Medicine. The subfields they focus on include Immunology, Ophthalmology, Epidemiology, Microbiology, and Rheumatology.

The main topics covered in their research address several areas in immunology and infectious diseases, including:

  • Ocular Diseases and Behçet's Syndrome
  • Cytomegalovirus and herpesvirus research
  • Reproductive tract infections research
  • Interferon and immune responses
  • Systemic Lupus Erythematosus Research
  • Immunodeficiency and Autoimmune Disorders
  • T-cell and B-cell Immunology

Among their recent scientific papers are the following:

  • Regulated Tristetraprolin Overexpression Dampens the Development and Pathogenesis of Experimental Autoimmune Uveitis, 2021, Frontiers in Immunology
  • The gut as a potential licensing site for central nervous system (CNS)-specific autoimmune lymphocytes, 2020, The Journal of Immunology
  • Laquinimod arrests development of experimental autoimmune uveitis (EAU) and inhibits related immune processes, in the context of altered gut microbiota, 2020, The Journal of Immunology
  • Laquinimod treatment attenuates EAU by inhibiting both the inductive and effector phases in an APC-dependent manner, 2025, bioRxiv (Cold Spring Harbor Laboratory)

The research has been published in venues such as The Journal of Immunology, Frontiers in Immunology, and bioRxiv (Cold Spring Harbor Laboratory).

Frequent collaborators with whom Igal Gery has coauthored multiple publications include:

  • Jihong Tang
  • Rachel R Caspi
  • Biying Xu
  • Reiko Horai
  • Mary J. Mattapallil

Best Publications

  • POTENTIATION OF THE T-LYMPHOCYTE RESPONSE TO MITOGENS : I. THE RESPONDING CELL

    Igal Gery;Richard K. Gershon;Byron H. Waksman

  • TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1

    Ahjoku Amadi-Obi;Cheng-Rong Yu;Xuebin Liu;Rashid M Mahdi

  • POTENTIATION OF THE T-LYMPHOCYTE RESPONSE TO MITOGENS

    Unknown

  • Suppressors of Cytokine Signaling Proteins Are Differentially Expressed in Th1 and Th2 Cells: Implications for Th Cell Lineage Commitment and Maintenance

    Charles E. Egwuagu;Cheng-Rong Yu;Meifen Zhang;Rashid M. Mahdi

  • T cell lines mediating experimental autoimmune uveoretinitis (EAU) in the rat.

    R R Caspi;F G Roberge;C G McAllister;M el-Saied

  • Chapter 3 Retinal specific antigens and immunopathogenic processes they provoke

    I. Gery;M. Mochizuki;R.B. Nussenblatt

  • Interleukin 1 is more than an interleukin.

    Joost J. Oppenheim;Igal Gery

  • TREATMENT OF INTRAOCULAR INFLAMMATORY DISEASE WITH CYCLOSPORIN A

    RobertB. Nussenblatt;AlainH. Rook;WaldonB. Wacker;AlanG. Palestine

  • The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degeneration.

    Jingsheng Tuo;Brena C. Smith;Christine M. Bojanowski;Annal D. Meleth

  • Cellular Immune Responsiveness of Uveitis Patients to Retinal S-Antigen

    Robert B. Nussenblatt;Robert B. Nussenblatt;Igal Gery;Igal Gery;Elmer J. Ballintine;Elmer J. Ballintine;Waldon B. Wacker;Waldon B. Wacker

  • Thymic expression of autoantigens correlates with resistance to autoimmune disease.

    C E Egwuagu;P Charukamnoetkanok;I Gery

  • Relationship between production and release of lymphocyte-activating factor (interleukin 1) by murine macrophages. 1. Effects of various agents

    Igal Gery;Igal Gery;Philip Davies;Philip Davies;Julia Derr;Julia Derr;Nancy Krett;Nancy Krett

  • Cyclosporin a. Inhibition of experimental autoimmune uveitis in Lewis rats.

    R B Nussenblatt;M M Rodrigues;W B Wacker;S J Cevario

  • Phenotype Switching by Inflammation-Inducing Polarized Th17 Cells, but Not by Th1 Cells

    Guangpu Shi;Catherine A. Cox;Barbara P. Vistica;Cuiyan Tan

  • Uveoretinitis and pinealitis induced by immunization with interphotoreceptor retinoid-binding protein.

    I Gery;B Wiggert;T M Redmond;T Kuwabara

  • Cellular immune responses of patients with uveitis to retinal antigens and their fragments.

    Marc D. de Smet;Marc D. de Smet;Joyce H. Yamamoto;Joyce H. Yamamoto;Manabu Mochizuki;Manabu Mochizuki;Igal Gery;Igal Gery

  • Analysis of the cytotoxic effects of light-exposed HEPES-containing culture medium.

    J. S. Zigler;J. L. Lepe-Zuniga;B. Vistica;I. Gery

  • Immunocytochemical demonstration of retinal S-antigen in the pineal organ of four mammalian species.

    Horst W. Korf;Morten Møller;Igal Gery;J. Samuel Zigler

  • Treatment of Uveitis by Oral Administration of Retinal Antigens: Results of a Phase I/II Randomized Masked Trial

    Robert B. Nussenblatt;Igal Gery;Howard L. Weiner;Frederick L. Ferris

  • Inflammatory Mediators in Uveitis: Differential Induction of Cytokines and Chemokines in Th1- Versus Th2-Mediated Ocular Inflammation

    Ellen F. Foxman;Meifen Zhang;Stephen D. Hurst;Tony Muchamuel

  • Recoverin is highly uveitogenic in Lewis rats.

    Igal Gery;Norman P. Chanaud;Eddy Anglade

Frequent Co-Authors

Eric F. Wawrousek
Eric F. Wawrousek National Institutes of Health
Robert B. Nussenblatt
Robert B. Nussenblatt National Institutes of Health
Chi-Chao Chan
Chi-Chao Chan National Institutes of Health
Gerald J. Chader
Gerald J. Chader University of Southern California
Toichiro Kuwabara
Toichiro Kuwabara Indiana University
Rachel R. Caspi
Rachel R. Caspi National Institutes of Health
Charles E. Egwuagu
Charles E. Egwuagu National Eye Institute
Barbara Wiggert
Barbara Wiggert National Institutes of Health
Manabu Mochizuki
Manabu Mochizuki Tokyo Medical and Dental University
Richard M. Siegel
Richard M. Siegel National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related online degrees can open various career pathways in healthcare and research. Many students start with foundational programs like online ADN programs for non nurses, which provide essential nursing knowledge without prior experience. This can serve as a stepping stone toward advanced nursing roles with clinical expertise.

Accelerated studies are also popular among individuals aiming to fast-track their education. Notably, accelerated NP program options allow for quicker transitions into nurse practitioner roles, which can complement immunology-focused careers in acute or specialized care settings.

Advanced practice nurses, including those transitioning from family-focused roles, may consider programs to move from fnp to acnp. This pathway enhances clinical skills in acute care environments, where immunological knowledge is critical for patient management.

Salary prospects vary by state and specialization. Understanding how much do dnp nurses make provides valuable insight into the financial rewards of Doctor of Nursing Practice roles, often linked to advanced immunology and healthcare careers.

Best Scientists Citing Igal Gery

Trending Scientists

Recently Published Articles